Mark Hahn

Mark Hahn

Directeur/Membre du Conseil chez ALSP ORCHID ACQUISITION CORPORATION I
63 ans
Health Technology
Communications
Technology Services

Profil

Mark W.
Hahn
is an Independent Director at ALSP Orchid Acquisition Corp.
I since 2021.
Mr. Hahn is a Director at Opterion Health AG.
Former roles include Independent Director at Soleno Therapeutics, Inc. from 2025 to 2026; Chief Financial Officer at Charles & Colvard Ltd. from 1984 to 1996; Chief Financial Officer, Secretary & Treasurer at Verona Pharma Ltd.; Chief Financial Officer at Equitel, Inc.; Principal at Ernst & Young LLP; Chief Financial Officer at Athenix Corp.
from 2008 to 2009; Chief Financial Officer & VP-Administration at Gigabeam Corp.
from 2007 to 2008; Chief Financial Officer at BuildLinks, Inc. from 2002 to 2007; Chief Financial Officer & Executive Vice President at Cempra Pharmaceuticals, Inc. and Cempra, Inc. from 2010 to 2017; Chief Financial Officer at Performaworks, Inc.; and Chief Financial Officer at Dova Pharmaceuticals, Inc. from 2018 to 2019.
Education includes an undergraduate degree from the University of Wisconsin-Milwaukee conferred in 1984.

Postes actifs de Mark Hahn

SociétésPosteDébut
ALSP ORCHID ACQUISITION CORPORATION I Directeur/Membre du Conseil 01/11/2021
Directeur/Membre du Conseil -

Anciens postes connus de Mark Hahn

SociétésPosteFin
SOLENO THERAPEUTICS, INC. Directeur/Membre du Conseil 15/05/2026
DOVA PHARMACEUTICALS, INC. Directeur Financier/CFO 12/11/2019
Directeur Financier/CFO 30/11/2017
Directeur Financier/CFO 01/11/2017
Directeur Financier/CFO 01/01/2009
Voir l'expérience en détail de Mark Hahn

Formation de Mark Hahn

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

49

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées15

Consumer Durables

Communications

Commercial Services

Process Industries

Communications

Technology Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Consumer Services

Health Technology

Health Services

Finance

- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇